Therefore, we hypothesize that rs2483205 may decrease CAD risk by modulating gene transcription and affecting TC levels, and it may be involved in adipogenesis by affecting PCSK9 levels, which enhances the risk of obesity. This evidence concerns the gene PCSK9 and obesity disorder.